HomeCompareCYCL vs CL

CYCL vs CL: Dividend Comparison 2026

CYCL yields 5449.59% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYCL wins by $143733464720535.25M in total portfolio value
10 years
CYCL
CYCL
● Live price
5449.59%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$143733464720535.28M
Annual income
$138,725,846,299,534,620,000.00
Full CYCL calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — CYCL vs CL

📍 CYCL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYCLCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYCL + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CYCL pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYCL
Annual income on $10K today (after 15% tax)
$463,215.26/yr
After 10yr DRIP, annual income (after tax)
$117,916,969,354,604,430,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, CYCL beats the other by $117,916,969,354,604,430,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYCL + CL for your $10,000?

CYCL: 50%CL: 50%
100% CL50/50100% CYCL
Portfolio after 10yr
$71866732360267.66M
Annual income
$69,362,923,149,767,310,000.00/yr
Blended yield
96.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

CYCL
No analyst data
Altman Z
-11.1
Piotroski
2/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYCL buys
0
CL buys
0
No recent congressional trades found for CYCL or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYCLCL
Forward yield5449.59%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$143733464720535.28M$40.8K
Annual income after 10y$138,725,846,299,534,620,000.00$5,401.96
Total dividends collected$143395578499210.66M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: CYCL vs CL ($10,000, DRIP)

YearCYCL PortfolioCYCL Income/yrCL PortfolioCL Income/yrGap
1← crossover$555,659$544,959.13$11,012$312.01+$544.6KCYCL
2$28,894,697$28,300,141.49$12,196$412.95+$28.88MCYCL
3$1,406,271,396$1,375,354,070.21$13,599$549.66+$1406.26MCYCL
4$64,062,549,885$62,557,839,491.91$15,288$736.64+$64062.53MCYCL
5$2,731,926,360,480$2,663,379,432,103.12$17,353$995.28+$2731926.34MCYCL
6$109,071,702,807,331$106,148,541,601,617.23$19,926$1,357.80+$109071702.79MCYCL
7$4,077,419,583,262,203$3,960,712,861,258,358.50$23,194$1,873.82+$4077419583.24MCYCL
8$142,739,514,323,666,200$138,376,675,369,575,650.00$27,439$2,621.52+$142739514323.64MCYCL
9$4,680,017,215,888,471,000$4,527,285,935,562,148,400.00$33,088$3,727.38+$4680017215888.44MCYCL
10$143,733,464,720,535,270,000$138,725,846,299,534,620,000.00$40,806$5,401.96+$143733464720535.25MCYCL

CYCL vs CL: Complete Analysis 2026

CYCLStock

Cycclone Inc., together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases. It also provides AM/HM bacteria based additives for livestock feed, which softens the livestock feed and restrain the growth and reproduction of pathogenic bacteria, as well as supplies beneficial nutriments, including organic acid, vitamins, enzyme, antibiotics, mycelium protein, and other growth-enhancing substances that balance the nutrients in the feed. In addition, the company offers FGW bacterial based preservatives that preserve animal specimens for scientific research; and preserve the freshness for agricultural produce. Further, it provides bacteria based fertilizer for application on plants, such as vegetable and fruit leaves. Additionally, the company engages in residential and commercial real estate investment. The company was formerly known as China Dasheng Biotechnology Co. and changed its name to Cycclone Inc. in May 2025. Cycclone Inc. was founded in 2004 and is based in Lanzhou, China.

Full CYCL Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this CYCL vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYCL vs SCHDCYCL vs JEPICYCL vs OCYCL vs KOCYCL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.